Ftse Mib
35.057,43
0,34%
DAX
20.390,75
0,20%
S&P 500
5.909,03
-1,11%
NASDAQ
19.489,68
-1,89%
Bitcoin
95.923,64
-1,01%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Milestone Pharmaceuticals Inc (MIST) Milestone Pharmaceuticals Inc (MIST) Notizie

Milestone Pharmaceuticals Inc

MIST
2,22
0,00 (0,00%)
08 Gen 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
07/1/202514:00GLOBEMilestone Pharmaceuticals Reports Inducement Grants Under..
25/11/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
12/11/202422:38EDGAR2Form S-3 - Registration statement under Securities Act of..
12/11/202422:36EDGAR2Form S-8 - Securities to be offered to employees in employee..
12/11/202415:12EDGAR2Form 8-K - Current report
12/11/202413:02EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
04/9/202414:07EDGAR2Form 8-K - Current report
29/8/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/8/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/8/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/8/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/8/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/8/202422:28EDGAR2Form 8-K - Current report
08/8/202422:13EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
17/7/202422:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/7/202422:16EDGAR2Form 3 - Initial statement of beneficial ownership of..
17/7/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/7/202422:15EDGAR2Form 3 - Initial statement of beneficial ownership of..
17/7/202400:06EDGAR2Form SC 13D/A - General Statement of Acquisition of..
15/7/202422:38EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
15/7/202422:36EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
15/7/202422:34EDGAR2Form DEF 14A - Other definitive proxy statements
15/7/202422:02EDGAR2Form 8-K - Current report
29/5/202413:09EDGAR2Form 8-K - Current report
22/5/202414:00GLOBEMilestone Pharmaceuticals Partners with Arrhythmia Alliance..
13/5/202413:34EDGAR2Form 8-K - Current report
13/5/202412:59EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
04/3/202415:00EDGAR2Form 8-K - Current report
01/3/202422:52EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
29/2/202413:00GLOBEMilestone Pharmaceuticals Announces Pricing of $30.0 Million..
28/2/202422:37GLOBEMilestone Pharmaceuticals Announces Proposed Public Offering..
26/2/202413:06EDGAR2Form 8-K - Current report
15/2/202402:56EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202413:10EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
Apertura: Min: Max:
Chiusura: 2,22

La tua Cronologia

NASDAQ
MIST
Milestone Pharmaceuticals
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network